Funding for this research was provided by:
Program “Investissements d’avenir” (ANR-10-IAIHU-06 (Agence Nationale de la Recherche-10-IA Agence Institut Hospitalo-Universitaire-6))
Program 'Infrastructure d’avenir en Biologie Santé (ANR-11-INBS-0006’)
Program "CHU de Bordeaux" ((coordination CIC EC7))
Marie-Curie Innovative Training Network BBDiag (Project ID: 721281)
Received: 21 July 2018
Accepted: 7 January 2019
First Online: 31 January 2019
Change Date: 14 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13195-022-01025-4
Ethics approval and consent to participate
: The ethics committee of the Pitié-Salpêtrière University Hospital approved the study protocol. All participants signed an informed consent form, given and explained to them 2 weeks before enrolment.
: The authors declare that they have no competing interests. HH serves as the Senior Associate Editor for the Journal Alzheimer’s and Dementia; he received lecture fees from Biogen and Roche, research grants from Pfizer, Avid, and MSD Avenir (paid to the institution), travel funding from Functional Neuromodulation, Axovant, Eli Lilly and company, Takeda and Zinfandel, GE-Healthcare and Oryzon Genomics, consultancy fees from Jung Diagnostics, Cytox Ltd., Axovant, Anavex, Takeda and Zinfandel, GE Healthcare, Oryzon Genomics, and Functional Neuromodulation, and participated in scientific advisory boards of Functional Neuromodulation, Axovant, Eli Lilly and company, Cytox Ltd., GE Healthcare, Takeda and Zinfandel, Oryzon Genomics and Roche Diagnostics.HH is a co-inventor in the following patents as a scientific expert and has received no royalties:• In Vitro Multi-parameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Patent Number: 8916388.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Patent Number: 8298784.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20120196300.• In Vitro Multi-parameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100062463.• In Vitro Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100035286.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Publication Number: 20090263822.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Patent Number: 7547553.• CSF Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases Publication Number: 20080206797.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Publication Number: 20080199966.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20080131921.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.